Stanford’s Review of the 63rd Annual American Society of Hematology Meeting

Registration fee includes course materials and certificate of participation.  Webinar information with the Zoom link will be provided to registered attendees the week of the event.

Registration Rate:
Physicians: $75
Nurses & Allied Health Professionals: $75
Industry: $75

Tuition may be paid by Visa, MasterCard or check. Your email address is used for critical information, including registration confirmation, evaluation, and certificate. Be sure to include an email address that you check frequently. If you prefer to pay by phone or check, please contact the Stanford Center for CME at (650) 497-8554 for assistance.

STAP-eligible employees can use STAP funds towards the registration fees for this activity.  Complete the STAP Reimbursement Request Form and submit to your department administrator. 

1. Implement the use of new chemotherapeutics and biologics in subpopulations of acute myeloid leukemia patients based on patient clinical and genetic profiles
2. Review new drug approvals and practical considerations for their safe and optimal use
3. Evaluate optimal sequencing and combinations of novel agents for CLL and lymphomas
4. Asses the role of new therapies in non-malignant hematology indications
5. Discuss available therapeutic options for patients with low- or high-risk myelodysplastic syndromes and utilize the revised international prognostic scoring system (IPSS-R) with new mutation data to classify patients for treatment

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 8.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Cancellation Policy
Cancellations received in writing no less than 20 days before the course will be refunded, less a 20% administrative fee. No refunds will be made on cancellations received after that date. Please send cancellation requests to [email protected].

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
     Name: Melissa Schwartz
     Title: Events Project Manager
     Email: [email protected]

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the below table. All of the relevant financial relationships listed for these individuals have been mitigated. 

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Jason Gotlib, MD

Co-Course Director, Faculty

Grant or research support-Incyte|Grant or research support-Novartis AG|Grant or research support-Kartos|Grant or research support-Blueprint Medicines|Grant or research support-Deciphera|Grant or research support-Cogent Biosciences|Grant or research support-Abbvie|Grant or research support-Bristol-Myers Squibb|Grant or research support-Protagonist Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis AG|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Kartos|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Blueprint Medicines|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Deciphera|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Cogent Biosciences|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Abbvie|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Protagonist Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-PharmaEssentia|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Imago Biosciences

William Shomali, MD
Clinical Assistant Professor, Hematology
Stanford University

Co-Course Director, Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte|Grant or research support-Incyte|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Blueprints Medicine

Tian Zhang, MD
Assistant Professor of Medicine, Hematology
Stanford University

Co-Course Director, Faculty

Grant or research support-Bristol-Myers Squibb

Ranjana Advani, MD
Saul A. Rosenberg, Professor of Lymphoma, Oncology
SHC - Cancer Center

Faculty

Advisor-Bristol-Myers Squib Aventis (Relationship has ended)|Advisor-Daiichi Sankyo|Advisor-Karyopharm (Relationship has ended)|Advisor-Incyte|Advisor-Epizyme|Grant or research support-Merck and Company, Inc.|Grant or research support-Regeneron|Grant or research support-Seattle Genetics|Grant or research support-Gilead|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sanofi-Aventis (Relationship has ended)|Advisor-ADC Therapuetics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Roche|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck and Company, Inc.

Danielle Atibalentja, MD, PhD
Instructor
Stanford School of Medicine

Faculty

Nothing to disclose

Caroline Berube, MD
Clinical Assoiate Professor of Medicine, HematologyMedical Director, Oral Anticoagulation Clinic
SHC

Faculty

Grant or research support-Pfizer, Inc.

Cailin Collins, MD, PhD
Fellow
Stanford Univeristy

Faculty

Nothing to disclose

Asiri Ediriwickrema, MD
Instructor
Stanford University

Faculty

Nothing to disclose

Sebastian Fernandez-Pol, MD
Clinical Assistant Professor, Pathology
Stanford University

Faculty

Nothing to disclose

Dita Anita Gratzinger, MD, PhD
Associate Professor, Pathology
Stanford University

Faculty

Nothing to disclose

Peter Greenberg, MD
Professor of Medicine
Stanford University Cancer Center
Us

Faculty

Grant or research support-Gilead|Grant or research support-GlaxoSmithKline|Grant or research support-Fibrogen|Grant or research support-Notable Labs

Marie Hollenhorst, MD, PhD
Clinical Instructor, Pathology, Hematology
Stanford University

Faculty

Consulting Fee-Johnson and Johnson (Relationship has ended)|Consulting Fee-Dova (Relationship has ended)

David Iberri, MD
Assistant Professor of Medicine (Hematology)
SHC - Cancer Center

Faculty

Nothing to disclose

Jyoti Kumar, MD
Affiliate, Dean's Office Operations, Fellow in Pathology
Stanford University

Faculty

Nothing to disclose

Lawrence Leung, MD
Maureen Lyles D'Ambrogio Professor in the School of Medicine, Hematology
Stanford University

Faculty

Nothing to disclose

Michaela Liedtke, MD
Associate Professor of Medicine (Hematology)
Stanford University School of Medicine

Faculty

Advisor-GlaxoSmithKline (Relationship has ended)|Advisor-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Advisor-Natera (Relationship has ended)|Advisor-Kite (Relationship has ended)|Advisor-KuraOncology (Relationship has ended)|Advisor-Oncopeptides (Relationship has ended)|Advisor-Bristol-Myers Squib Aventis (Relationship has ended)|Advisor-Sanofi-Aventis (Relationship has ended)|Advisor-Alnylam (Relationship has ended)|Advisor-Karyopharm (Relationship has ended)|Honoraria-Pfizer, Inc. (Relationship has ended)

Gabriel Mannis, MD
Associate Professor of Medicine (Hematology)
Stanford University School of Medicine

Faculty

Advisor-Astellas|Advisor-Abbvie|Advisor-Genentech|Consulting Fee-Macrogenics

Beth A. Martin, MD
Clinical Associate Professor, Medicine - Hematology
Stanford University School of Medicine

Faculty

Nothing to disclose

Lori Muffly, MD
Associate Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine

Faculty

Advisor-Kite|Advisor-CTI Biopharma (Relationship has ended)|Advisor-Amgen (Relationship has ended)|Paid consultant-Astellas|Grant or research support-BMS|Grant or research support-Jasper|Grant or research support-Kite|Honoraria-Adaptive|Grant or research support-Adaptive

Tait Shanafelt, MD
Jeanie and Stew Richie Profressor, Hematology
Stanford University

Faculty

Grant or research support-Pharmacyclics, Inc.|Grant or research support-Genentech, Inc.

James Zehnder, MD
Professor of Medicine, Pathology, Hematology
Stanford University

Faculty

Nothing to disclose

Saturday, February 12, 2022